Patents by Inventor Grant Yonehiro

Grant Yonehiro has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Generation and Selection of Embryos in Vitro
    Publication number: 20160257918
    Abstract: Methods of improved monitoring, testing and/or culturing of ova and/or sperm for in vitro fertilization are described herein. Methods of improved monitoring, testing and/or culturing of embryos during ex vivo pre-implantation selection are also described. The ova, sperm or embryos may be derived from wild animals or zoo animals. The ova, sperm or embryos can be mammalian, such as human, bovine, porcine, ovine, caprine, equine, canine, feline, murine, or the like.
    Type: Application
    Filed: March 4, 2016
    Publication date: September 8, 2016
    Inventors: Kevin Chapman, Volker Kurz, Peggy Radel, Grant Yonehiro
  • METHOD FOR THE TREATMENT OF RADIATION-INDUCED NEUTROPENIA BY ADMINISTRATION OF A MULTI-PEGYLATED GRANULOCYTE COLONY STIMULATING FACTOR (G-CSF) VARIANT
    Publication number: 20100183543
    Abstract: The invention relates to a method for treating or preventing radiation-induced neutropenia in a patient exposed to radiation by administering to the patient a multi-PEGylated granulocyte colony stimulating factor (G-CSF) variant.
    Type: Application
    Filed: September 18, 2009
    Publication date: July 22, 2010
    Inventors: Grant Yonehiro, Thomas J. MacVittie
  • Coronary artery disease treatment
    Publication number: 20050191278
    Abstract: The invention provides a method of treating coronary artery disease in a human patient comprising directly injecting into an ischemic cardiac muscle, via multiple injections to different points of the cardiac muscle, a dose of a pharmaceutical composition comprising a pharmaceutically acceptable carrier and a replication-deficient adenoviral vector comprising a nucleic acid sequence encoding an angiogenic peptide operably linked to a promoter, whereby the coronary artery disease is treated.
    Type: Application
    Filed: April 12, 2005
    Publication date: September 1, 2005
    Applicants: GenVec, Inc., Warner-Lambert Company
    Inventors: Milton Pressler, Donald Black, Paul Fischer, Henrik Rasmussen, Margaret Samyn, Grant Yonehiro